Nanomedicine to Drive the Next Generation of Precision Medicine and Personalised Healthcare: Dr. Jitendra Singh

Union Minister Dr. Jitendra Singh stated at the World Congress on Nanomedicine 2026 in New Delhi that nanomedicine will drive the next generation of precision medicine and personalized healthcare. The Department of Biotechnology (DBT) is supporting 210 R&D projects in nanomedicine with ₹174 crore, spanning areas like targeted drug delivery, cancer nanomedicine, nano-diagnostics, and regenerative medicine. Prominent examples highlighting India's growing capabilities include oral insulin nanoparticles and nanobots for breast cancer. Additionally, India has established a regulatory framework for nanopharmaceuticals through guidelines jointly developed by DBT, ICMR, and CDSCO, and supports emerging biotechnology enterprises through BIRAC programs.